In SummaryIn addition to approved boosters from Johnson & Johnson and Moderna, the FDA also authorized “mixing and matching” booster shots.
The U.S. Food and Drug Administration (FDA) authorized booster shots of Moderna and Johnson & Johnson COVID-19 vaccines for tens of millions of people on Wednesday, CNBC reported.
“Today’s actions demonstrate our commitment to public health in proactively fighting against the COVID-19 pandemic,” said FDA Commissioner Dr. Janet Woodcock. “As the pandemic continues to impact the country, science has shown that vaccination continues to be the safest and most effective way to prevent COVID-19, including the most serious consequences of the disease, such as hospitalization and death.”
The boosters will further protect vulnerable Americans, such as people 65 years old and older, people between 18 and 64 years old who are at high risk and people who may have increased exposure to COVID through work, against COVID-19, the FDA said.
People who took Moderna’s two-dose vaccine should get the booster shot six months after being fully vaccinated. In comparison, Johnson & Johnson vaccine recipients could get their booster at least two months after receiving their initial dose.
The FDA’s decision comes when it’s also recommending “mixing and maxing” vaccines, which allows people to get a different booster from the one they were originally administered.
According to a National Institutes of Health study, people who got the J&J vaccine are better off getting a Pfizer or Moderna booster shot because it offers additional antibodies.
“I would highly encourage people to talk to their primary care doctors about if they should receive boosters,” Dr. Geoffrey Mount Varner, an ER physician and decisions expert, told BNC.
The Centers for Disease Control and Prevention has an advisory meeting on Thursday to examine Johnson & Johnson and Moderna’s booster shot data, according to The New York Times.